Literature DB >> 9122613

ICAM-2 provides a costimulatory signal for T cell stimulation by allogeneic class II MHC.

C Carpenito1, A M Pyszniak, F Takei.   

Abstract

To examine the functional role of intercellular adhesion molecule (ICAM)-2 (CD102) in antigen presentation to T cells, the I-E(d)-transfected murine fibroblastic L cell line RT10.3 (H-2(k)) was transfected with murine ICAM-1 or ICAM-2 and tested for their abilities to stimulate C3H/He (H-2(k)) splenic T cells. The expression of ICAM-1 or ICAM-2 on RT10.3 cells significantly increased the stimulation of T cells in an LFA-1 (CD11a/CD18)-dependent manner as determined by thymidine incorporation. This enhanced T cell response was also observed when combinations of untransfected RT10.3 cells and ICAM-1- or ICAM-2-transfected L cells were used as stimulators, indicating that ICAM-1 and ICAM-2 deliver a costimulatory signal instead of merely enhanced T cell adhesion to antigen presenting cells. The T cells stimulated with ICAM-transfected RT10.3 in the primary response vigorously responded to BALB/c (H-2(d)) spleen cells in a secondary allogeneic stimulation. In contrast, T cells stimulated with untransfected RT10.3 in the primary response did not respond to BALB/c spleen cells in the secondary response. Significant secondary responses to a third party stimulator, C57BL/6 spleen cells (H-2(b)), were observed regardless of ICAM expression on RT10.3 cells in the primary stimulation. These results indicate that ICAM-2 as well as ICAM-1 not only enhance antigen presentation mediated by allogeneic class II MHC but also provide a costimulatory signal to T cells. This costimulatory signal may be important in the aversion of an anergic state.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9122613     DOI: 10.1046/j.1365-3083.1997.d01-391.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  4 in total

1.  Loss of LFA-1, but not Mac-1, protects MRL/MpJ-Fas(lpr) mice from autoimmune disease.

Authors:  Christopher G Kevil; M John Hicks; Xiaodong He; Junxuan Zhang; Christie M Ballantyne; Chander Raman; Trenton R Schoeb; Daniel C Bullard
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

2.  Leflunomide inhibits transendothelial migration of peripheral blood mononuclear cells.

Authors:  J Grisar; M Aringer; M D Köller; G H Stummvoll; D Eselböck; B Zwölfer; C W Steiner; B Zierhut; L Wagner; P Pietschmann; J S Smolen
Journal:  Ann Rheum Dis       Date:  2004-12       Impact factor: 19.103

3.  Inhibition of ICAM2 induces radiosensitization in oral squamous cell carcinoma cells.

Authors:  T Ishigami; K Uzawa; K Fushimi; K Saito; Y Kato; D Nakashima; M Higo; Y Kouzu; H Bukawa; T Kawata; H Ito; H Tanzawa
Journal:  Br J Cancer       Date:  2008-03-18       Impact factor: 7.640

4.  ICAM-2 expression mediates a membrane-actin link, confers a nonmetastatic phenotype and reflects favorable tumor stage or histology in neuroblastoma.

Authors:  Karina Jin Yoon; Doris A Phelps; Rebecca A Bush; Joanna S Remack; Catherine A Billups; Joseph D Khoury
Journal:  PLoS One       Date:  2008-11-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.